ReviR Therapeutics today announced a strategic investment from CureCMT to support the launch of a precision medicine platform for Charcot-Marie-Tooth disease (CMT). The platform will combine isogenic ...
Promatix Biosciences Highlights The Power Of Its Logic-Gated Proteomics-Driven Bispecific Discovery Platform To Expand The Tumour-Selective Target Space For Next-Generation Adcs At AACR 2026. Promati ...
Investigating a common gene in three very different species – axolotls, mice and zebrafish – scientists have discovered the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results